Diffusion of Partnership for Health to Health Care and Medical Agencies Serving Persons Living With HIV/AIDS, 40704-40708 [05-13848]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 70, Number 134 (Thursday, July 14, 2005)]
[Notices]
[Pages 40704-40708]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-13848]



[[Page 40704]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Diffusion of Partnership for Health to Health Care and Medical 
Agencies Serving Persons Living With HIV/AIDS

    Announcement Type: New.
    Funding Opportunity Number: CDC-RFA-AA068.
    Catalog of Federal Domestic Assistance Number: 93.941.
    DATES:
    Letter of Intent Deadline: July 25, 2005.
    Application Deadline: August 8, 2005.

I. Funding Opportunity Description

    Authority: Public Health Service Act, Section 301(a), [42 U.S.C. 
241(a)], as amended.

    Background: Partnership for Health \1\ (PfH) is a brief counseling 
program, delivered by medical providers, for men and women living with 
HIV/AIDS. The program is designed to improve patient-provider 
communication about disclosure of HIV serostatus and HIV prevention. 
PfH is based on a social cognitive model that uses message framing, 
repetition, and reinforcement to increase the patient's knowledge, 
skills, and motivations to engage in behaviors that reduce risk for HIV 
transmission. The AIDS Education and Training Centers (AETCs) have 
diffused PfH to the 12 new CDC-funded PA 04064 agencies. This 
project will expand the diffusion of PfH to 35-40 more clinics, via 
intervention training and technical assistance.
---------------------------------------------------------------------------

    \1\ Richardson, J.L., Milam, J., McCutchan, A., Stoyanoff, S., 
Bolan, R., Weiss, J., Kemper, C., Larsen, R.A., Hollander, H., 
Weismuller, P., Chou, C.P., Marks, G. (2004). Effect of brief safer-
sex counseling by medical providers to HIV-1 seropositive patients: 
A multi-clinic assessment. AIDS, 18:1179-1186.
---------------------------------------------------------------------------

    Purpose: The purpose of the program is to diffuse the PfH 
intervention to health care professionals, and other public or private 
medical facilities, that provide services to HIV-positive persons 
through national training and technical assistance for planning, 
implementation, and evaluation of PfH. Partnership for Health is an 
evidence-based HIV prevention intervention designed to integrate HIV 
prevention into medical services for persons living with HIV/AIDS. This 
program addresses the Healthy People 2010 focus area of HIV infection. 
It also addresses Strategy 3 of the Advancing HIV Prevention 
initiative: Prevent new infections by working with persons diagnosed 
with HIV and with their partners.
    This project supports the following Division of HIV/AIDS Prevention 
(DHAP) Strategic Plan priorities:
    Goal 1, Objective 1: Among persons living with HIV, increase the 
proportion who consistently engage in behaviors that reduce risk for 
HIV transmission or acquisition.
    Goal 4, Objective 2: Increase the number of evidence-based 
interventions and the proportion of prevention providers funded by CDC 
who successfully provide demonstrably effective HIV prevention 
interventions.
    Measurable outcomes of the program will align with the following 
performance goal for the National Center for HIV, STD, and TB 
Prevention (NCHSTP):
    Goal 1. Decrease the number of persons at high risk for acquiring 
or transmitting HIV infection.
    This announcement is only for nonresearch activities supported by 
CDC/ATSDR. If research is proposed, the application will not be 
reviewed. For the definition of research, please see the CDC Web site 
at the following Internet address: https://www.cdc.gov/od/ads/
opspoll1.htm.
    Activities: Awards activities for this program are as follows:
     In cooperation with CDC and other grantees funded under 
this announcement, the grantee will develop and implement a marketing 
plan to promote the diffusion of the PfH intervention to health care 
and other public or private medical facilities providing services to 
HIV-positive persons within their public health designated area.
     The grantee will identify and contact at least two health 
care and other public or private medical facilities that provide 
services to HIV-positive persons and that are interested in 
implementing PfH. This information will be shared with CDC and other 
grantees funded under this announcement to ensure adequate coverage of 
PfH in the United States and its territories.
     In accordance with PfH trainer curriculum and related 
intervention materials, the grantee will plan, schedule, and conduct 
PfH training sessions for health care and other public or private 
medical facilities providing services to HIV-positive persons. The 
number of agencies trained will range from two to eight depending on 
regional clinic demand and epidemiologic need. Each PfH training 
session will include: (1) A 45-minute orientation program on site; (2) 
a 4\1/2\-hour training program on site; and (3) a 2-hour booster 
program on site. The grantee will work in partnership with CDC and 
other grantees under this program announcement to establish a national 
training calendar for PfH.
     The grantee will provide two trainers, who have completed 
the PfH training-of-trainers conducted by the University of Southern 
California, to conduct each of the three components of the PfH training 
and to provide technical assistance.
     The grantee will provide technical assistance to trained 
agencies to support planning, implementation, and evaluation of PfH 
during the program year. Technical assistance will be provided by 
telephone, e-mail, or face-to-face. The grantee will coordinate this 
technical assistance with CDC, which may include using a CDC Web-based 
tracking system.
     The grantee, along with CDC and other grantees funded 
under this announcement, will develop and implement a quality assurance 
plan for the training delivery and technical assistance.
     The grantee will obtain a PfH intervention package and 
related materials (e.g., starter kit, technical assistance guide, 
sample budget) for training participants from the PfH researcher, Jean 
Richardson, at the Keck School of Medicine, University of Southern 
California, Department of Preventive Medicine and Institute for 
Prevention Research, 1441 Eastlake Avenue, Suite 3409, Los Angeles, CA 
90089-9175. Phone: 323-865-0343. E-mail: jeanr@usc.edu.
     The grantee will submit the list of agencies to be trained 
and schedule of training sessions to the CDC Project Officer and other 
grantees funded under this program announcement.
     The grantee will submit an interim report summarizing the 
activities and deliverables for the first half of the project period, 
including training provided and scheduled, dates of training, 
attendance at training sessions, a narrative description of the 
response of the organization and problems/challenges encountered, 
lessons learned, recruitment efforts for PfH training, technical 
assistance provided, and other activities.
     The grantee will submit a final project report summarizing 
the activities and deliverables for the project period, including 
training completed, lessons learned, challenges, recruitment efforts 
for PfH training, technical assistance provided, and other activities.
    In a cooperative agreement, CDC staff members are substantially 
involved in the program activities, above and beyond routine grant 
monitoring.
    CDC activities for this program are as follows:

[[Page 40705]]

     Provide technical assistance in the general operation of 
this HIV prevention project, including but not limited to detailed 
advice on steps to accomplish the grantee activities.
     Consult on the choice of agencies selected for PfH 
training, by suggesting selection criteria, assisting in identifying 
potential agencies in the event that a grantee has difficulty, and 
approving the final choices.
     Monitor and evaluate progress and deliverables of this 
project through frequent telephone contact; observation of PfH training 
sessions; and review of implementation plans, interim and final 
progress reports, quality assurance plans, marketing plans, and 
training schedules.
     Conduct monthly calls with individual grantees and monthly 
conference calls with all grantees funded to provide PfH training to 
encourage exchange of information and technology transfer among 
grantees.
     Make recommendations aimed at solving problems and 
improving the quality and timeliness of grantee activities.

II. Award Information

    Type of Award: Cooperative Agreement. CDC involvement in this 
program is described in the preceding activities section.
    Fiscal Year Funds: FY 2005.
    Approximate Total Funding: $350,000.
    Approximate Number of Awards: 11 (eleven).
    Approximate Average Award: $40,000. (This amount is for the 12-
month budget period, and includes both direct and indirect costs.)
    Floor of Award Range: $20,000.
    Ceiling of Award Range: $60,000. (This ceiling is for the first 12-
month budget period.)
    Anticipated Award Date: August 31, 2005.
    Budget Period Length: 12 months.
    Project Period Length: Two years.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the federal government.

III. Eligibility Information

III.1. Eligible applicants

    Applications may be submitted by academic medical centers meeting 
the requirements of the criteria listed under III.3. Other.

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    If you request a funding amount greater than the ceiling of the 
award range, your application will be considered non-responsive and 
will not be entered into the review process. You will be notified that 
your application did not meet the submission requirements.
    Special Requirements: If any of the aforementioned academic medical 
centers do not have the following qualifications, they will not be 
eligible to apply for this program: (1) Experience conducting targeted, 
multidisciplinary education and training programs for health care 
providers treating persons living with HIV/AIDS (e.g., physicians, 
advanced practice nurses, physician assistants, nurses, oral health 
professionals, and pharmacists); (2) experience collaborating with 
organizations funded by the Ryan White Comprehensive AIDS Resources 
Emergency (CARE) Act, area health education centers, community-based 
HIV/AIDS organizations, and medical and health professional 
organizations; and (3) location in the region or locality of the 
agencies to be trained as identified in the application.
    If your application is incomplete or nonresponsive to the special 
requirements listed in this section, it will not be entered into the 
review process. You will be notified that your application did not meet 
submission requirements.
     Late applications will be considered nonresponsive. See 
section ``IV.3. Submission Dates and Times'' for more information on 
deadlines.
     Note: Title 2 of the United States Code, Section 1611, 
states that an organization described in Section 501(c)(4) of the 
Internal Revenue Code that engages in lobbying activities is not 
eligible to receive federal funds constituting an award, grant, or 
loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161-1.
    Electronic Submission: CDC strongly encourages the applicant to 
submit the application electronically by utilizing the forms and 
instructions posted for this announcement on https://www.Grants.gov, the 
official Federal agency wide E-grant Web site. Only applicants who 
apply on-line are permitted to forego paper copy submission of all 
application forms.
    Paper Submission: Application forms and instructions are available 
on the CDC Web site, at the following Internet address: https://
www.cdc.gov/od/pgo/forminfo.htm.
    If access to the Internet is not available, or if there is 
difficulty accessing the forms on-line, contact the CDC Procurement and 
Grants Office Technical Information Management Section (PGO-TIM) staff 
at 770-488-2700 and the application forms can be mailed.

IV.2. Content and Form of Submission

    Letter of Intent (LOI): Your LOI must be written in the following 
format:
     Maximum number of pages: 1.
     Font size: 12-point unreduced.
     Single spaced.
     Paper size: 8.5 by 11 inches.
     Page margin size: 1 inch.
     Printed on only one side of page.
     Written in plain language, avoid jargon.
    Your LOI must contain the following information:
     Intention to submit an application.
     Approximate number of organizations to be targeted for 
training.
     Name, address, and telephone number for the applicant.
     Name, address, and telephone number for contact person for 
this application.
     Number and title of this RFA.
    Application: You must submit a project narrative with your 
application forms. The narrative must be submitted in the following 
format:
     Maximum number of pages: 15. If your narrative exceeds the 
page limit, only the first 15 pages will be reviewed.
     Font size: 12-point unreduced.
     Double spaced.
     Paper size: 8.5 by 11 inches.
     Page margin size: One inch.
     Printed on only one side of page.
     Held together only by rubber bands or metal clips; not 
bound in any other way.
     Cover page--funding opportunity number and title of this 
announcement.
     Table of contents--with the major sections and page 
numbering, including each attachment.
     Consecutive page numbering throughout the document, 
including attachments.
    Your narrative should address activities to be conducted over the 
entire project period, and it must include the following items in the 
order listed:

A. Introduction
B. Statement of Need
C. Capacity

[[Page 40706]]

D. Implementation Plan
E. Quality Assurance Plan
F. Evaluation of the project and services provided
G. Performance Goals
H. Budget (will not count in the stated page limit)
A. Introduction
    The introduction narrative should consist of a one-page abstract of 
the proposal, a complete table of contents to the application and its 
appendices, and text addressing each required element. Beginning with 
the first page of text, number all pages clearly and sequentially, 
including each page in the appendices.
B. Statement of Need
    Describe the need for the integration of HIV prevention services 
into medical care for persons living with HIV/AIDS in the region or 
community that will be targeted for recruitment. Describe known or 
estimated demand for PfH training in the proposed region or community. 
Describe how organizations will be targeted for recruitment for PfH 
based on epidemiologic data, number of organizations that will be 
selected for training, and selection process, if demand exceeds 
capacity to provide PfH training and technical assistance. Describe the 
populations served by the organizations to be recruited.
C. Capacity
    a. Demonstrate capacity to conduct the activities required for this 
project, including all mentioned under other eligibility requirements 
and experience with the population(s) for whom the intervention was 
designed. Include evidence of experience conducting similar trainings 
and technical assistance to Ryan White CARE Act-funded sites, and other 
health care professionals and medical facilities providing services to 
HIV-positive persons.
    b. Clearly describe the proposed staffing, e.g., show percentages 
of each staff member's commitment to this and other projects, the 
division of duties and responsibilities for this project, brief 
position descriptions for existing and proposed personnel, and any 
partnerships with HIV prevention agencies.
    c. Demonstrate that the applicant's staff has the expertise to 
complete this project. Name the staff members who are key to the 
completion of the project. Provide a brief description of their 
strengths that relate to this project. Include their curriculum vitae 
in the appendix.
    d. Describe current protocols for quality assurance and evaluation 
of high-quality training and technical assistance. Include examples of 
how quality assurance or evaluation findings were used to improve 
services.
    e. Briefly describe compliance regarding the inclusion of women and 
ethnic and racial groups in the proposed activities or justification 
when representation is limited or absent.
D. Implementation Plan
    Describe the applicant's plan and timeframe for implementation of 
this project, including but not limited to these activities:
    a. Identifying health care and medical facilities that are 
interested in receiving PfH training and implementing PfH intervention.
    b. Planning, scheduling, and implementing PfH training sessions.
    c. Providing technical assistance and other methods to support 
implementation of PfH.
    d. Communicating regularly with CDC regarding progress of this 
project and for review and approval of aforementioned activities.
E. Quality Assurance Plan
    Describe the quality assurance plan that will be used to maintain 
high-quality training and technical assistance to the organizations 
trained. Include the staff responsibility for quality assurance 
activities.
F. Evaluation of the Project and Services Provided
    Describe the process for evaluating the trained organizations' 
satisfaction with training, technical assistance, and support for PfH 
implementation.
G. Performance Goals
    Describe the measurable outcomes of the project and how these will 
align with one or more of the following performance goals:
    a. Strengthen the capacity nationwide to monitor the epidemic, 
develop and implement effective HIV prevention interventions, and 
evaluate prevention programs.
    b. Decrease the number of persons at high risk for acquiring or 
transmitting HIV infection.
H. Budget (Will Not Count in the Stated Page Limit)
    Provide a detailed, line-item budget for the project; justify each 
line item. This cooperative agreement is for purposes of coordinating a 
national training initiative to diffuse PfH into medical practice. Any 
application requesting greater than eight percent in indirect costs 
will not be considered for review and will be returned to the 
applicant.
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit. This additional information includes:
     Curriculum vitae or resumes.
     Organizational charts.
     References.
     Quality assurance tools.
     Evaluation tools.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, access https://www.dunandbradstreet.com or call 1-866-705-
5711. For more information, see the CDC Web site at this Internet 
address: https://www.cdc.gov/od/pgo/funding/pubcommt.htm.
    If your application form does not have a DUNS number field, please 
write your DUNS number at the top of the first page of your application 
or include your DUNS number in your application cover letter.
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    LOI Deadline Date: July 25, 2005.
    CDC requests that you send a LOI if you intend to apply for this 
program. Although the LOI is not required, not binding, and does not 
enter into the review of your subsequent application, the LOI will be 
used to gauge the level of interest in this program and to allow CDC to 
plan the application review.
    Application Deadline Date: August 8, 2005.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. eastern time on the deadline 
date.
    Applications may be submitted electronically at https://
www.grants.gov. Applications completed on-line through Grants.gov are 
considered formally submitted when the applicant organization's 
Authorizing Official electronically submits the application to https://
www.grants.gov. Electronic applications will be considered as having 
met the deadline if the application has been submitted

[[Page 40707]]

electronically by the applicant organization's Authorizing Official to 
Grants.gov on or before the deadline date and time.
    If submittal of the application is done electronically through 
Grants.gov (https://www.grants.gov), the application will be 
electronically time/date stamped, which will serve as receipt of 
submission. Applicants will receive an e-mail notice of receipt when 
CDC receives the application.
    If submittal of the LOI or application is by the United States 
Postal Service or commercial delivery service, the applicant must 
ensure that the carrier will be able to guarantee delivery by the 
closing date and time. If CDC receives the submission after the closing 
date due to: (1) Carrier error, when the carrier accepted the package 
with a guarantee for delivery by the closing date and time, or (2) 
significant weather delays or natural disasters, the applicant will be 
given the opportunity to submit documentation of the carrier's 
guarantee. If the documentation verifies a carrier problem, CDC will 
consider the submission as having been received by the deadline.
    If a hard copy application is submitted, CDC will not notify the 
applicant upon receipt of the submission. If questions arise on the 
receipt of the application, the applicant should first contact the 
carrier. If the applicant still has questions, contact the PGO-TIM 
staff at (770) 488-2700. The applicant should wait two to three days 
after the submission deadline before calling. This will allow time for 
submissions to be processed and logged.
    This announcement is the definitive guide on LOI and application 
content, submission address, and deadline. It supersedes information 
provided in the application instructions. If the submission does not 
meet the deadline above, it will not be eligible for review, and will 
be discarded. The applicant will be notified the application did not 
meet the submission requirements.

IV.4. Intergovernmental Review of Applications

    Executive Order 12372 does not apply to this program.

IV.5. Funding Restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
     Funds may not be used for research.
     Reimbursement of pre-award costs is not allowed.
     Indirect charges are limited to eight percent.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement should have been in 
effect less than 12 months.
    Guidance for completing your budget can be found on the CDC Web 
site, at the following Internet address: https://www.cdc.gov/od/pgo/
funding/budgetguide.htm.

IV.6. Other Submission Requirements

    LOI Submission Address: Submit your LOI by express mail, delivery 
service, fax, or e-mail to: Dr. Miriam E. Phields, CDC/NCHSTP/DHAP/CBB, 
1600 Clifton Road, Mail Stop E-40, Atlanta, GA 30333. Telephone: 404-
639-4957. Fax: 404-639-0915. E-mail: MPhields@cdc.gov.
    Application Submission Address:
    Electronic Submission: CDC strongly encourages applicants to submit 
applications electronically at https://www.Grants.gov. The application 
package can be downloaded from https://www.Grants.gov. Applicants are 
able to complete it off-line, and then upload and submit the 
application via the Grants.gov Web site. E-mail submissions will not be 
accepted. If the applicant has technical difficulties in Grants.gov, 
costumer service can be reached by e-mail at https://www.grants.gov/
CustomerSupport or by phone at 1-800-518-4726 (1-800-518-GRANTS). The 
Customer Support Center is open from 7 a.m. to 9 p.m. eastern time, 
Monday through Friday.
    CDC recommends that submittal of the application to Grants.gov 
should be early to resolve any unanticipated difficulties prior to the 
deadline. Applicants may also submit a back-up paper submission of the 
application. Any such paper submission must be received in accordance 
with the requirements for timely submission detailed in Section IV.3. 
of the grant announcement. The paper submission must be clearly marked: 
``BACK-UP FOR ELECTRONIC SUBMISSION.'' The paper submission must 
conform to all requirements for non-electronic submissions. If both 
electronic and back-up paper submissions are received by the deadline, 
the electronic version will be considered the official submission.
    It is strongly recommended that the applicant submit the grant 
application using Microsoft Office products (e.g., Microsoft Word, 
Microsoft Excel, etc.). If the applicant does not have access to 
Microsoft Office products, a PDF file may be submitted. Directions for 
creating PDF files can be found on the Grants.gov Web site. Use of file 
formats other than Microsoft Office or PDF may result in the file being 
unreadable by staff.

Or:

    Paper Submission: Applicants should submit the original and two 
hard copies of the application by mail or express delivery service to: 
Technical Information Management--CDC-RFA-AA068, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.

V. Application Review Information

V.1. Criteria

    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goals stated in the ``Purpose'' section of 
this announcement. Measures must be objective and quantitative, and 
must measure the intended outcome. These measures of effectiveness must 
be submitted with the application and will be an element of evaluation.
    Your application will be evaluated against the following criteria:.
1. Capacity (30 Points)
    Does the applicant have the overall ability to perform the proposed 
activities, including all mentioned under other eligibility 
requirements and experience with populations for whom the intervention 
was designed, as reflected in their staff's qualifications and 
availability? How well has the applicant demonstrated that proposed 
staff members have experience with PfH training, Ryan White CARE Act-
funded sites, and other health care and medical organizations, and 
quality assurance to provide high-quality professional education, 
training, and technical assistance? Has the applicant provided evidence 
that the proposed trainers completed the training-of-trainers for PfH 
from Dr. Jean Richardson at the University of Southern California? Are 
there existing support staff, equipment, and facilities?
2. Implementation Plan (30 Points)
    Is the plan adequate and feasible to carry out the proposed 
objectives and performance goals in a timely manner, including agency 
recruitment and selection, implementation, process monitoring and 
evaluation, technical assistance, and other support for PfH 
implementation? Does the plan include quantitative process measures? 
Are the staff roles clearly defined? As described, will the staff be 
sufficient to accomplish the program goals?

[[Page 40708]]

3. Statement of Need (20 Points)
    To what extent does the applicant justify the need for this program 
within the region or community targeted? Do the epidemiologic and other 
data support this need? Does evidence demonstrate a demand for PfH 
intervention?
4. Quality Assurance (10 Points)
    To what extent has the applicant demonstrated an adequate plan to 
maintain high-quality services?
5. Evaluation (10 Points)
    To what extent has the applicant demonstrated ability to measure 
and achieve process outcomes?
6. Budget and Justification
    (Reviewed but not scored.)

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff, and for responsiveness by NCHSTP. 
Incomplete applications and applications that are nonresponsive to the 
eligibility criteria will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    An objective review panel will evaluate complete and responsive 
applications according to the criteria listed in the preceding ``V.1. 
Criteria'' section. The objective review panel will be composed of CDC 
and other federal employees.
    In addition, the following factors may affect the funding decision:
     Maintaining geographic diversity.
     Giving preference to organizations in certain geographic 
areas with high HIV seroprevalence or a large number of AIDS cases.
    CDC will provide justification for any decision to fund out of rank 
order.

V.3. Anticipated Announcement and Award Dates

    Award date: August 31, 2005.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Award (NoA) from the 
CDC Procurement and Grants Office. The NoA will be the only binding, 
authorizing document between the recipient and CDC. The NoA will be 
signed by an authorized Grants Management Officer and mailed to the 
recipient fiscal officer identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

    45 CFR part 74 and part 92.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: https://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:

 AR-4 HIV/AIDS Confidentiality Provisions
 AR-5 HIV Program Review Panel Requirements
 AR-6 Patient Care
 AR-8 Public Health System Reporting Requirements
 AR-9 Paperwork Reduction Act Requirements
 AR-10 Smoke-Free Workplace Requirements
 AR-11 Healthy People 2010
 AR-12 Lobbying Restrictions
 AR-14 Accounting System Requirements
 AR-15 Proof of Non-Profit Status
 AR-24 Health Insurance Portability and Accountability Act 
Requirements
 AR-25 Release and Sharing of Data

    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: https://www.cdc.gov/od/
pgo/funding/ARs.htm.
    An additional Certifications form from the PHS 5161-1 application 
needs to be included in your Grants.gov electronic submission only. 
Refer to https://www.cdc.gov/od/pgo/funding/PHS5161-1-
Certifications.pdf. Once this form is filled out, attach it to your 
Grants.gov submission as Other Attachment Forms.

VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, due no more than 30 days after the 
performance period. The progress report will serve as your noncompeting 
continuation application and must contain the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period and Program Proposed Activity Objectives.
    d. Budget.
    e. Measures of Effectiveness.
    f. Additional Requested Information.
    2. Financial status report and annual progress report, due 60 days 
after the end of the budget period.
    3. Final financial and performance reports, due no more than 90 
days after the end of the project period.
    These reports must be mailed to the Grants Management or Contract 
Specialist listed in the ``Agency Contacts'' section of this 
announcement.

VII. Agency Contacts

    We encourage inquiries concerning this announcement.
    For general questions, contact: Technical Information Management 
Section, CDC Procurement and Grants Office, 2920 Brandywine Road, 
Atlanta, GA 30341. Telephone: 770-488-2700.
    For program technical assistance, contact: Dr. Miriam E. Phields, 
Project Officer, CDC/NCHSTP/DHAP/CBB, 1600 Clifton Road, Mail Stop E-
40, Atlanta, GA 30333. Telephone: 404-639-4957. Fax: 404-639-0915. E-
mail: MPhields@cdc.gov.
    For financial, grants management, or budget assistance, contact: 
Angie Tuttle, Grants Management Specialist, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341. Telephone: 404-498-
1913. E-mail: ATuttle@cdc.gov.

VIII. Other Information

    This announcement and other CDC funding opportunity announcements 
can be found on the CDC Web site, Internet address: https://www.cdc.gov. 
Click on ``Funding'' then ``Grants and Cooperative Agreements.''

    Dated: July 8, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-13848 Filed 7-13-05; 8:45 am]
BILLING CODE 4163-18-P